Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
In a Bank of America note published on Monday, the analyst argues that brand mail pharmacy margins can be 5-10% (and in many cases pharmacies are losing money on GLP-1 scripts), which are significantly lower than the 50% gross margins we estimate HIMS is capturing in its GLP-1 portfolio. It is unlikely that HIMS will follow Ros lead to partner with brand manufacturers, the analyst added, because HIMS differentiation and success is tied to its own brand equity for its products and selling branded pharmaceutical drugs would both hurt margins and cannibalize its core products. Diversifying Beyond the Major GLP-1 Drugs Hims could also look to broaden its weight loss offerings, leveraging its established telehealth platform to incorporate non-drug-based solutions
DAPA-HF Trial Committees and Investigators
Unknown impurities According to Novo Nordisks analysis, compounded semaglutide products contain unknown impurities
Chitin surface was used to develop a sandwich ELISA to detect the chimeric human protein c-myc-GST-IL8 cloned and expressed in Escherichia coli
It depends on which woman is asking
Your path to better health, delivered direct to your door.
